Association of serum homocysteine and coronary heart disease in an Iranian urban population

Acta Cardiologica Sinica

Volumn 25, Issue 3, 2009, Pages 142-146

  Bandarian, Fatemeh ^a   Fakhrzadeh, Hossein ^a   Heshmat, Ramin ^a   Nouri, Masoumeh ^a   Larijani, Bagher ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary heart disease; Electrocardiography; Homocysteine

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; IRAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; URBAN POPULATION; VITAMIN BLOOD LEVEL;

EID: 70449586622     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Stein JH, McBride PE. Hyperhomocysteinemia and atherosclerotic vascular disease. Arch Intern Med 1998;158:1301-1306
2. Hankey JH, Eikelboom JW Homocysteine and vascular disease. Lancet 1999;354:407-413
3. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinaemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-1155
4. Nygard O, Nodrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-236 (Pubitemid 27310438)
5. Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non insulin dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1998;18:133-138 (Pubitemid 28047610)
6. Taghavi M. Features of death in 18 province of Iran in 2000. Tehran, Tandis Publications, 2002.
7. Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk 1998;5:229-232 (Pubitemid 29030108)
8. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057
9. Christen WG, Ajani UA, Glynn RJ, et al. Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual? Arch Intern Med 2000;160:422-434
10. Genest JJ Jr, McNamara JR, Salem DN, et al. Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990;16:1114-1119
11. Arnesen E, Refsum H, Bonaa KH, et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24:704-709
12. Evans RW, Shaten BJ, Hempel JD, et al. Homocysteine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 1997;17:1947-1953 (Pubitemid 28057094)
13. Folsom AR, Nieto FJ, McGovern PG, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998;98:204-210
14. Halil M, Yavuz B, Yavuz BB, et al. Novel cardiovascular risk factors in the elderly and their correlation with the Framingham risk score. J Cardiovasc Med (Hagerstown) 2008;9:683-687
15. Clarke R, Lewington S, Landray M. Homocysteine, renal function, and risk of cardiovascular disease. Kidney Int 2003;84: S131-S3. (Pubitemid 36513394)
16. Omland T, Samuelsson A, Hartford M, et al. Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 2000;160:1834-1840 (Pubitemid 30418822)
17. Fakhrzadeh H, Ghotbi S, Pourebrahim R, et al. Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study. BMC Public Health 2006;6:29.
18. Fakhrzadeh H, Ghotbi S, Pourebrahim R, et al. Plasma homocysteine concentration and blood pressure in healthy Iranian adults: the Tehran Homocysteine Survey (2003-2004). J Hum Hypertens 2005;19:869-876 (Pubitemid 41637603)
19. WHO MONICA Project: Geographical variation in the major risk factors of coronary heart disease in men and women aged 25-64 years. World Health Stat Q 1988;41:115-140
20. Heshmat R, Fakhrzadeh H, Pour Ebrahim R, et al. Cardiovascular risk factors study in the inhabitants of Tehran University of Medical Sciences population lab: statistical design and sampling. Iran J Diabetes Lipid Disorders 2004;3:21-26
21. Blackburn H. Electrocardiographic classification for population comparisons. The Minnesota code. J Electrocardiol 1969;2:5-9.
22. Rose GA, Blackburn H, Gillum RF, et al. Cardiovascular survey methods. WHO Monograph Series 56, 2nd ed. Geneva: WHO, 1982.
23. Retterstol L, Paus B, Bohn M, et al. Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study. J Intern Med 2003; 253:284-292 (Pubitemid 36315199)
24. Chasan-Taber L, Selhub J, Rosenberg IH, et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 1996;15:136-143 (Pubitemid 26105689)
25. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000;355:523-527 (Pubitemid 30088671)
26. Mehta KN, Chag MC, Parikh KH, et al. Effect of folate treatment on homocysteinemia in cardiac patients: A prospective study. Indian J Pharmacol 2005;37:13-17 (Pubitemid 40239135)
27. Kuo HK. Relationship between homocysteine and cardiovascular diseases in older adults. J Am Geriatr SOC 2004;52:1955-1956 (Pubitemid 41710286)
28. Vrentzos G, Papadakis JA, Malliaraki N, et al. Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort. Angiology 2004;55:517-524 (Pubitemid 39237919)
29. Nikkari ST, Kalela A, Koivu TA, et al. Serum homocysteine does not associate with uncomplicated coronary heart disease. Eur J Clin Invest 2001;31:581-585 (Pubitemid 32642888)
30. Lonn E, Yusuf S, Arnold MJ, et al. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators.Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567-1577
31. Bonaa KH, Njolstad I, Ueland PM, et al. NORVIT Trial Investigators Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-1588